Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum

Thromboembolism is a common and deadly consequence of COVID-19 infection for hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and early observational reports, expert consensus and guidance documents have strongly encouraged the use of prophylactic anticoagulation fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Geoffrey D, Burnett, Allison, Allen, Arthur, Ansell, Jack, Blumenstein, Marilyn, Clark, Nathan P, Crowther, Mark, Dager, William E, Deitelzweig, Steven B., Ellsworth, Stacy, Garcia, David, Kaatz, Scott, Raffini, Leslie, Rajasekhar, Anita, Beek, Andrea Van, Minichiello, Tracy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111941/
https://www.ncbi.nlm.nih.gov/pubmed/35579732
http://dx.doi.org/10.1007/s11239-022-02643-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111941/
https://www.ncbi.nlm.nih.gov/pubmed/35579732
http://dx.doi.org/10.1007/s11239-022-02643-3

Ejemplares similares